Toxys: Next generation genotoxicity testing
Toxys is an innovative dutch CRO that provides next-generation genotoxicity testing services to rapidly identify potential carcinogenic properties of novel compounds during the early phases of product and drug development.
Our ToxTracker assay is a state-of-the-art stem cell-based reporter system to identify various potentially carcinogenic properties of novel compounds with a superior sensitivity and specificity compared to conventional in vitro (geno)toxicity tests available on the market.